MMR Catch up Campaign: reasons for refusal to consent.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 2082853)

Published in Arch Dis Child on July 01, 2006

Authors

I Hadjikoumi, K V Niekerk, C Scott

Articles by these authors

(truncated to the top 100)

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys (1997) 8.58

Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science (2001) 5.16

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys (2000) 5.06

Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital Health Stat 2 (1999) 4.74

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys (2000) 3.00

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst (1995) 2.64

An activating mutation of AKT2 and human hypoglycemia. Science (2011) 2.60

Phenotypes Associated with SHOX Deficiency. J Clin Endocrinol Metab (2001) 2.51

Diagnostic strategies used in primary care. BMJ (2009) 2.23

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther (2008) 2.06

Antidepressants and side effects. Aust N Z J Psychiatry (1995) 2.02

Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys (1993) 1.99

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys (2001) 1.98

A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem (1999) 1.90

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2012) 1.83

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys (1997) 1.72

Functional versatility in the CRP-FNR superfamily of transcription factors: FNR and FLP. Adv Microb Physiol (2001) 1.71

Frequency and effect of negative comments ("badmouthing") on medical students' career choices. Acad Med (1996) 1.71

Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys (2000) 1.71

Henoch-Schönlein purpura: a review. Am Fam Physician (1998) 1.67

Prenatal detection of unbalanced chromosomal rearrangements by array CGH. J Med Genet (2005) 1.63

Genetic and morphological characterization of Cladobotryum species causing cobweb disease of mushrooms. Appl Environ Microbiol (1999) 1.60

A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58

GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J Neurosci (1996) 1.54

RTOG's first quality of life study--RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 1.52

Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis (2010) 1.47

MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat (2006) 1.45

Validity of self-reported mammography in low-income African-American women. Am J Prev Med (1998) 1.39

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol (1999) 1.39

Inhibition of neutrophil respiratory burst and cytokine priming by gamma-linolenic acid. Br J Surg (1996) 1.39

Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol (1998) 1.37

Event-related fMRI with simultaneous and continuous EEG: description of the method and initial case report. Neuroimage (2001) 1.37

Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab (2000) 1.36

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys (2000) 1.34

Dilated cardiomyopathy in children: determinants of outcome. Br Heart J (1994) 1.31

Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys (1993) 1.30

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (1998) 1.30

Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood (1997) 1.27

Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys (2001) 1.27

Genomic sequence and transcriptional profile of the boundary between pericentromeric satellites and genes on human chromosome arm 10q. Hum Mol Genet (2000) 1.25

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. Int J Radiat Oncol Biol Phys (2000) 1.23

The pathological substrate of limbic epilepsy: neuronal loss in the medial dorsal thalamic nucleus as the consistent change. Epilepsia (2000) 1.20

Redox redux. Geobiology (2009) 1.20

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol (1996) 1.19

A distinct molecular profile associated with mucinous epithelial ovarian cancer. Br J Cancer (2006) 1.15

The DNA sequence and comparative analysis of human chromosome 10. Nature (2004) 1.14

Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys (1996) 1.13

Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. Pediatrics (1995) 1.13

Corneal ulcer and adverse reaction rates in premarket contact lens studies. Am J Ophthalmol (1991) 1.10

NHS distribution of funds unfair. BMJ (1992) 1.10

Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. J Clin Oncol (2000) 1.09

Everting suture correction of lower lid involutional entropion. Br J Ophthalmol (1999) 1.09

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol (1996) 1.07

Communicable disease surveillance: Notification of infectious diseases in Canada. Can J Infect Dis (1996) 1.06

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys (1999) 1.06

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int J Radiat Oncol Biol Phys (1993) 1.05

Childhood sexual abuse, psychological distress, and medical use among women. Psychosom Med (2000) 1.04

Diagnostic laparoscopy: a 5-year experience in a hepatology training program. Am J Gastroenterol (1995) 1.04

The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord (2010) 1.04

Control of mannose/galactose ratio during galactomannan formation in developing legume seeds. Planta (1992) 1.03

Genetic polymorphism at the kappa chain locus in mice: comparisons of restriction enzyme hybridization fragments of variable and constant region genes. Immunogenetics (1985) 1.02

Outcomes research in cancer clinical trial cooperative groups: the RTOG model. Qual Life Res (2004) 1.01

Construction of synthetic genes using PCR after automated DNA synthesis of their entire top and bottom strands. Nucleic Acids Res (1991) 1.00

Acute gastrointestinal bleeding due to Meckel's diverticulum heterotopic gastric mucosa. Ital J Gastroenterol (1996) 0.99

Identification of a novel C-terminal variant of beta II spectrin: two isoforms of beta II spectrin have distinct intracellular locations and activities. J Cell Sci (2000) 0.98

SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol (1998) 0.97

Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer (1995) 0.97

Neurotrophins stimulate chemotaxis of embryonic cortical neurons. Eur J Neurosci (1997) 0.96

University-industry partnership. Science (2001) 0.95

Rape: management in a noninstitutional setting. Obstet Gynecol (1983) 0.94

Ultrasonography of the femoral vessels in the groin: implications for vascular access. Anaesthesia (2000) 0.94

Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys (1996) 0.93

Implications of positive surgical margins. Laryngoscope (1993) 0.93

Fluorescence properties of o-phthaldialdehyde derivatives of amino acids. Biochim Biophys Acta (1979) 0.93

Heat shock protein 101 effects in A. thaliana: genetic variation, fitness and pleiotropy in controlled temperature conditions. Mol Ecol (2008) 0.91

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys (2000) 0.91

The functional morphology of the coronary microcirculation in the dog. Microvasc Res (1974) 0.91

Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or "deletion with positional effect" syndrome? J Med Genet (2005) 0.91

The nested structure of cancer symptoms. Implications for analyzing co-occurrence and managing symptoms. Methods Inf Med (2010) 0.91

Castleman's disease: an unusual cause of mediastinal mass and anemia. Clin Ter (2002) 0.90

Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1. J Immunol (1996) 0.90

Renal complications in HIV. Int J Clin Pract (2007) 0.90

Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1997) 0.89

Clinical correlation of radiological spinal stenosis after standardization for vertebral body size. Clin Radiol (2007) 0.88

Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation. Am J Med Genet A (2008) 0.88

Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507. J Clin Oncol (2001) 0.88

Rapid immunoblot and kinase assay tests for a syndromal form of X linked mental retardation: Coffin-Lowry syndrome. J Med Genet (1998) 0.87

Retrograde aortic dissection during cardiopulmonary bypass: "nonoperative" management. Ann Thorac Surg (1977) 0.87

Respiratory virus surveillance. FluWatch project, 1997-1998. Can Commun Dis Rep (1998) 0.87

A follow-up study of the characteristics of dean's letters. Acad Med (2001) 0.86

All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma. J Neurooncol (1997) 0.86

5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems. Br J Pharmacol (2000) 0.86

The development of theory of mind in deaf children. J Child Psychol Psychiatry (1998) 0.85

Nursing in the public sphere: breaching the boundary between research and policy. J Adv Nurs (2000) 0.85

Two operons that encode FNR-like proteins in Lactococcus lactis. Mol Microbiol (1999) 0.85

Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02. Int J Radiat Oncol Biol Phys (1995) 0.85

Detection of cathepsin S cysteine protease in human brain tumour microdialysates in vivo. Br J Neurosurg (2007) 0.85

Characterization of two metastatic subpopulations originating from a single human colon carcinoma. Cancer Res (1983) 0.85

Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groups. Qual Life Res (2000) 0.84